Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence

References

• Achkar, J. M., & Jenny-Avital, E. R. (2011). Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. The Journal of Infectious Diseases, 204(4), S1179–S86. https://doi.org/10.1093/infdis/jir451
   PubMedGoogle Scholar
• Adigun, R., & Singh, R. (2022). Tuberculosis. StatPearls Publishing LLC.
   Google Scholar
• Al-blewi, F., Rezki, N., Naqvi, A., Qutb Uddin, H., Al-Sodies, S., Messali, M., Aouad, M. R., & Bardaweel, S. (2019). A profile of the in vitro anti-tumor activity and in silico adme predictions of novel benzothiazole amide-functionalized imidazolium ionic liquids. International Journal of Molecular Sciences, 20(12), 2865. https://doi.org/10.3390/ijms20122865
   PubMed Web of Science ®Google Scholar
• Aly, A. A., El-Sheref, E. M., Bakheet, M. E. M., Mourad, M. A. E., Bräse, S., Ibrahim, M. A. A., Nieger, M., Garvalov, B. K., Dalby, K. N., & Kaoud, T. S. (2019). Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma. Bioorganic Chemistry, 82, 290–305. https://doi.org/10.1016/j.bioorg.2018.10.044
   PubMed Web of Science ®Google Scholar
• Anagani, B., Singh, J., Bassin, J. P., Besra, G. S., Benham, C., Reddy, T. R. K., Cox, J. A. G., & Goyal, M. (2020). Identification and validation of the mode of action of the chalcone anti-mycobacterial compounds. Cell Surface (Amsterdam, Netherlands), 6, 100041. https://doi.org/10.1016/j.tcsw.2020.100041
   PubMedGoogle Scholar
• Ayati, A., Falahati, M., Irannejad, H., & Emami, S. (2012). Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 20(1), 46–46.
   PubMedGoogle Scholar
• Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007
   PubMed Web of Science ®Google Scholar
• Bloom, B. R., Atun, R., Cohen, T., Dye, C., Fraser, H., Gomez, G. B., Knight, G., Murray, M., Nardell, E., Rubin, E., Salomon, J., Vassall, A., Volchenkov, G., White, R., Wilson, D., & Yadav, P. (2017). Tuberculosis., in: K.K. Holmes, S. Bertozzi, B.R. Bloom, P. Jha (Eds.), Major infectious diseases. The International Bank for Reconstruction and Development/The World Bank.
   Google Scholar
• Bojarska, J., Remko, M., Breza, M., Madura, I. D., Kaczmarek, K., Zabrocki, J., & Wolf, W. M. (2020). A supramolecular approach to structure-based design with a focus on synthons hierarchy in ornithine-derived ligands: review, synthesis, experimental and in silico studies. Molecules, 25(5), 1135. https://doi.org/10.3390/molecules25051135
   PubMed Web of Science ®Google Scholar
• Collins, L., & Franzblau, S. G. (1997). Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrobial Agents and Chemotherapy, 41(5), 1004–1009. https://doi.org/10.1128/AAC.41.5.1004
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Dey, R., Nandi, S., Samadder, A., Saxena, A., & Saxena, K. A. (2020). Exploring the potential inhibition of candidate drug molecules for clinical investigation based on their docking or crystallographic analyses against M. tuberculosis enzyme targets. Current Topics in Medicinal Chemistry, 20(29), 2662–2680. https://doi.org/10.2174/1568026620666200903163921
   PubMed Web of Science ®Google Scholar
• Ertl, P., Rohde, B., & Selzer, P. (2000). Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. Journal of Medicinal Chemistry, 43(20), 3714–3717. https://doi.org/10.1021/jm000942e
   PubMed Web of Science ®Google Scholar
• Fakih, T. M., & Dewi, M. L. (2020). In silico Identification of characteristics spike glycoprotein of SARS-CoV-2 in the development novel candidates for COVID-19 infectious diseases. Journal of Biomedicine and Translational Research, 6(2), 48–52. https://doi.org/10.14710/jbtr.v6i2.7590
   Google Scholar
• Gomes, M. N., Braga, R. C., Grzelak, E. M., Neves, B. J., Muratov, E., Ma, R., Klein, L. L., Cho, S., Oliveira, G. R., Franzblau, S. G., & Andrade, C. H. (2017). QSAR-driven design, synthesis and discovery of potent Chalcones derivatives with antitubercular activity. European Journal of Medicinal Chemistry, 137, 126–138. https://doi.org/10.1016/j.ejmech.2017.05.026
   PubMed Web of Science ®Google Scholar
• Gupta, D., & Jain, D. K. (2015). Chalcone derivatives as potential antifungal agents: Synthesis, and antifungal activity. Journal of Advanced Pharmaceutical Technology & Research, 6(3), 114–117. https://doi.org/10.4103/2231-4040.161507
   PubMed Web of Science ®Google Scholar
• Hadda, B. T., Rastija, V., AlMalki, F., Titi, A., Touzani, R., Mabkhot, N. Y., Khalid, S., Zarrouk, A., & Siddiqui, S. B. (2021). Petra/osiris/molinspiration and molecular docking analyses of 3-hydroxy-Indolin-2-one derivatives as potential antiviral agents. Current Computer-Aided Drug Design, 17(1), 123–133. https://doi.org/10.2174/1573409916666191226110029
   PubMed Web of Science ®Google Scholar
• He, X., Alian, A., & Ortiz de Montellano, P. R. (2007). Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorganic & Medicinal Chemistry, 15(21), 6649–6658. https://doi.org/10.1016/j.bmc.2007.08.013
   PubMed Web of Science ®Google Scholar
• Jung, J.-C., Lee, Y., Min, D., Jung, M., & Oh, S. (2017). Practical synthesis of chalcones derivatives and their biological activities. Molecules, 22(11), 1872. https://doi.org/10.3390/molecules22111872
   PubMed Web of Science ®Google Scholar
• Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Research, 45(D1), D353–D361. https://doi.org/10.1093/nar/gkw1092
   PubMed Web of Science ®Google Scholar
• Khan, T., Dixit, S., Ahmad, R., Raza, S., Azad, I., Joshi, S., & Khan, A. R. (2017). Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its com.p. Journal of Chemical Biology, 10(3), 91–104. https://doi.org/10.1007/s12154-017-0167-y
   PubMedGoogle Scholar
• Kuldeep, J., Sharma, S. K., Sharma, T., Singh, B. N., & Siddiqi, M. I. (2021). Targeting mycobacterium tuberculosis enoyl-acyl carrier protein reductase using computational tools for identification of potential inhibitor and their biological activity. Molecular Informatics, 40(5), e2000211. https://doi.org/10.1002/minf.202000211
   PubMed Web of Science ®Google Scholar
• Lin, Y. M., Zhou, Y., Flavin, M. T., Zhou, L. M., Nie, W., & Chen, F. C. (2002). Chalconess and flavonoids as anti-tuberculosis agents. Bioorganic & Medicinal Chemistry, 10(8), 2795–2802. https://doi.org/10.1016/S0968-0896(02)00094-9
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• López, S. N., Castelli, M. V., Zacchino, S. A., Domínguez, J. N., Lobo, G., Charris-Charris, J., Cortés, J. C., Ribas, J. C., Devia, C., Rodríguez, A. M., & Enriz, R. D. (2001). In vitro antifungal evaluation and structure-activity relationships of a new series of Chalcones derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorganic & Medicinal Chemistry, 9(8), 1999–2013. https://doi.org/10.1016/S0968-0896(01)00116-X
   PubMed Web of Science ®Google Scholar
• Mabkhot, Y. N., Alatibi, F., El-Sayed, N. N. E., Al-Showiman, S., Kheder, N. A., Wadood, A., Rauf, A., Bawazeer, S., & Hadda, T. B. (2016). Antimicrobial activity of some novel armed thiophene derivatives and petra/osiris/molinspiration (POM) analyses. Molecules, 21(2), 222. https://doi.org/10.3390/molecules21020222
   PubMed Web of Science ®Google Scholar
• Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: a powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602
   PubMed Web of Science ®Google Scholar
• Miller-Petrie, M., Pant, S., & Laxminarayan, R. (2017). Drug-resistant infections. In K. K. Holmes, S. Bertozzi, B.R. Bloom, & P. Jha (Eds.), Major infectious diseases. The International Bank for Reconstruction and Development/The World Bank.
   Google Scholar
• Milne, G. W. A. (2010). Software review of ChemBioDraw 12.0. Journal of Chemical Information and Modeling, 50(11), 2053–2053. https://doi.org/10.1021/ci100385n
   Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Nguta, J. M., Appiah-Opong, R., Nyarko, A. K., Yeboah-Manu, D., Addo, P. G., Otchere, I., & Kissi-Twum, A. (2016). Antimycobacterial and cytotoxic activity of selected medicinal plant extracts. Journal of Ethnopharmacology, 182, 10–15. https://doi.org/10.1016/j.jep.2016.02.010
   PubMed Web of Science ®Google Scholar
• Pham The, H., González-Álvarez, I., Bermejo, M., Mangas Sanjuan, V., Centelles, I., Garrigues, T. M., & Cabrera-Pérez, M. (2011). In silico prediction of Caco-2 cell permeability by a classification QSAR approach. Molecular Informatics, 30(4), 376–385. https://doi.org/10.1002/minf.201000118
   PubMed Web of Science ®Google Scholar
• Polkam, N., Ramaswamy, V. R., Rayam, P., Allaka, T. R., Anantaraju, H. S., Dharmarajan, S., Perumal, Y., Gandamalla, D., Yellu, N. R., Balasubramanian, S., & Anireddy, J. S. (2016). Synthesis, molecular properties prediction and anticancer, antioxidant evaluation of new edaravone derivatives. Bioorganic & Medicinal Chemistry Letters, 26(10), 2562–2568. https://doi.org/10.1016/j.bmcl.2016.03.024
   PubMed Web of Science ®Google Scholar
• Preethi, L., Ganamurali, N., Dhanasekaran, D., & Sabarathinam, S. (2021). Therapeutic use of guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect. Obesity Medicine, 24, 100346. https://doi.org/10.1016/j.obmed.2021.100346
   Google Scholar
• Rammohan, A., Reddy, J. S., Sravya, G., Rao, C. N., & Zyryanov, G. V. (2020). Chalcones synthesis, properties and medicinal applications: A review. Environmental Chemistry Letters, 18(2), 433–458. https://doi.org/10.1007/s10311-019-00959-w
   Web of Science ®Google Scholar
• Sabarathinam, S., & Vijayakumar, M. T. (2021). A short exploration of selected sensitive CYP3A4 substrates (probe drug). Drug Metabolism Letters, 14(1), 2–4. https://doi.org/10.2174/1872312814666200811110024
   PubMedGoogle Scholar
• Salehi, B., Quispe, C., Chamkhi, I., Omari, N. E., Balahbib, A., Sharifi-Rad, J., Bouyahya, A., Akram, M., Iqbal, M., Docea, A. O., Caruntu, C., Leyva-Gómez, G., Dey, A., Martorell, M., Calina, D., López, V., & Les, F. (2020). Pharmacological properties of Chalcones: A review of preclinical including molecular mechanisms and clinical evidence. Frontiers in Pharmacology, 11, 592654. https://doi.org/10.3389/fphar.2020.592654
   PubMed Web of Science ®Google Scholar
• Saxena, K. A., & Singh, A. (2019). Mycobacterial tuberculosis enzyme targets and their inhibitors. Current Topics in Medicinal Chemistry, 19(5), 337–355. https://doi.org/10.2174/1568026619666190219105722
   PubMed Web of Science ®Google Scholar
• Shah, V. R., Bhaliya, J. D., & Patel, G. M. (2021). In silico approach: docking study of oxindole derivatives against the main protease of COVID-19 and its comparison with existing therapeutic agents. Journal of Basic and Clinical Physiology and Pharmacology, 32(3), 197–214. https://doi.org/10.1515/jbcpp-2020-0262
   PubMedGoogle Scholar
• Suresh, J., Baek, S. C., Ramakrishnan, S. P., Kim, H., & Mathew, B. (2018). Discovery of potent and reversible MAO-B inhibitors as furanoChalconess. International Journal of Biological Macromolecules, 108, 660–664. https://doi.org/10.1016/j.ijbiomac.2017.11.159
   PubMed Web of Science ®Google Scholar
• Suresh, A. J., Nandini, S., Sangeetha, K., Dhivya, L. S., & Surya, P. R. (2021). Design, synthesis and in vitro biological evaluation of pyridine, thiadazole, benzimidazole and acetyl thiophene analogues as anti tubercular agents targeting enzyme InhA. Current Computer-Aided Drug Design, 17(6), 773–784. https://doi.org/10.2174/1573409916666200724152827
   PubMed Web of Science ®Google Scholar
• Taira, J., Umei, T., Inoue, K., Kitamura, M., Berenger, F., Sacchettini, J. C., Sakamoto, H., & Aoki, S. (2020). Improvement of the novel inhibitor for Mycobacterium enoyl-acyl carrier protein reductase (InhA): a structure-activity relationship study of KES4 assisted by in silico structure-based drug screening. The Journal of Antibiotics, 73(6), 372–381. https://doi.org/10.1038/s41429-020-0293-6
   PubMedGoogle Scholar
• Takayama, K., Wang, C., & Besra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clinical Microbiology Reviews, 18(1), 81–101. https://doi.org/10.1128/CMR.18.1.81-101.2005
   PubMed Web of Science ®Google Scholar
• Tanner, L., Haynes, R. K., & Wiesner, L. (2019). An in vitro ADME and in vivo Pharmacokinetic study of novel TB-active decoquinate derivatives. Frontiers in Pharmacology, 10, 120. https://doi.org/10.3389/fphar.2019.00120
   PubMed Web of Science ®Google Scholar
• Tariq, M., Sirajuddin, M., Ali, S., Khalid, N., Tahir, M. N., Khan, H., & Ansari, T. M. (2016). Pharmacological investigations and petra/osiris/molinspiration (POM) analyses of newly synthesized potentially bioactive organotin(IV) carboxylates. Journal of Photochemistry and Photobiology. B, Biology, 158, 174–183. https://doi.org/10.1016/j.jphotobiol.2016.02.028
   PubMed Web of Science ®Google Scholar
• Wang, Z., Chen, Y., Liang, H., Bender, A., Glen, R. C., & Yan, A. (2011). P-glycoprotein substrate models using support vector machines based on a comprehensive data set. Journal of Chemical Information and Modeling, 51(6), 1447–1456. https://doi.org/10.1021/ci2001583
   PubMed Web of Science ®Google Scholar
• Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R., & Sacchettini, J. C. (2007). Sacchettini mechanism of thioamide drug action against tuberculosis and leprosy. The Journal of Experimental Medicine, 204(1), 73–78. https://doi.org/10.1084/jem.20062100
   PubMed Web of Science ®Google Scholar
• Zhu, H., Tang, L., Zhang, C., Wei, B., Yang, P., He, D., Zheng, L., & Zhang, Y. (2019). Synthesis of chalcone derivatives: Inducing apoptosis of HepG2 cells via regulating reactive oxygen species and mitochondrial pathway. Frontiers in Pharmacology, 10, 1341.
   PubMed Web of Science ®Google Scholar
• Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017). Chalcone: A privileged structure in medicinal chemistry. Chemical Reviews, 117(12), 7762–7810. https://doi.org/10.1021/acs.chemrev.7b00020
   PubMed Web of Science ®Google Scholar